MA26980A1 - Antagonistes des recepteurs d'histamine. - Google Patents

Antagonistes des recepteurs d'histamine.

Info

Publication number
MA26980A1
MA26980A1 MA27233A MA27233A MA26980A1 MA 26980 A1 MA26980 A1 MA 26980A1 MA 27233 A MA27233 A MA 27233A MA 27233 A MA27233 A MA 27233A MA 26980 A1 MA26980 A1 MA 26980A1
Authority
MA
Morocco
Prior art keywords
receptor antagonists
histamine receptor
histamine
receptor
antagonist
Prior art date
Application number
MA27233A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26980A1 publication Critical patent/MA26980A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Antagonistes des récepteurs d'histamine La présente invention propose une association (a) d'un antagoniste des récepteurs d'histamine H1 et (b) d'un antagoniste qui est au moins 10 fois plus sélectif pour le récepteur d'histamine H4 que pour le récepteur d'histamine H3, des compositions la contenant ainsi que leurs utilisations.
MA27233A 2001-01-17 2003-07-11 Antagonistes des recepteurs d'histamine. MA26980A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
MA26980A1 true MA26980A1 (fr) 2004-12-20

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27233A MA26980A1 (fr) 2001-01-17 2003-07-11 Antagonistes des recepteurs d'histamine.

Country Status (32)

Country Link
EP (1) EP1353657A1 (fr)
JP (1) JP2004517883A (fr)
KR (1) KR20030069216A (fr)
CN (1) CN1486178A (fr)
AP (1) AP2002002401A0 (fr)
AR (1) AR032101A1 (fr)
BG (1) BG107834A (fr)
BR (1) BR0206502A (fr)
CA (1) CA2435121A1 (fr)
CR (1) CR6983A (fr)
CZ (1) CZ20031853A3 (fr)
DO (1) DOP2002000325A (fr)
EA (1) EA200300537A1 (fr)
EC (1) ECSP034692A (fr)
EE (1) EE200300335A (fr)
GB (1) GB0101223D0 (fr)
GT (1) GT200200003A (fr)
HU (1) HUP0302767A2 (fr)
IL (1) IL156087A0 (fr)
IS (1) IS6818A (fr)
MA (1) MA26980A1 (fr)
MX (1) MXPA03006408A (fr)
NO (1) NO20033223L (fr)
OA (1) OA12440A (fr)
PA (1) PA8537101A1 (fr)
PL (1) PL362793A1 (fr)
PY (1) PY0200477A (fr)
SK (1) SK8572003A3 (fr)
SV (1) SV2003000849A (fr)
TN (1) TNSN02003A1 (fr)
WO (1) WO2002056871A2 (fr)
ZA (1) ZA200304180B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
EP1545596A4 (fr) * 2002-09-06 2005-12-28 Janssen Pharmaceutica Nv Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthme
WO2004066960A2 (fr) * 2003-01-28 2004-08-12 Schering Corporation Combinaison d'antagonistes des recepteurs h1, h3 et h4 en vue du traitement d'inflammations pulmonaires allergiques et non allergiques, de congestions et de rhinites allergiques
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére
CN119823227B (zh) * 2025-01-14 2025-07-04 广州迪卡德营养科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
DOP2002000325A (es) 2003-01-31
EP1353657A1 (fr) 2003-10-22
GT200200003A (es) 2002-08-19
PY0200477A (es) 2004-06-01
ECSP034692A (es) 2003-08-29
PL362793A1 (pl) 2004-11-02
NO20033223D0 (no) 2003-07-16
JP2004517883A (ja) 2004-06-17
WO2002056871A2 (fr) 2002-07-25
IS6818A (is) 2003-05-15
SV2003000849A (es) 2003-01-13
ZA200304180B (en) 2004-06-15
TNSN02003A1 (fr) 2005-12-23
BG107834A (bg) 2004-01-30
AR032101A1 (es) 2003-10-22
CR6983A (es) 2003-11-25
SK8572003A3 (en) 2004-07-07
CN1486178A (zh) 2004-03-31
AP2002002401A0 (en) 2002-03-31
IL156087A0 (en) 2003-12-23
BR0206502A (pt) 2003-10-21
KR20030069216A (ko) 2003-08-25
EE200300335A (et) 2003-12-15
HUP0302767A2 (hu) 2003-11-28
OA12440A (en) 2006-05-22
PA8537101A1 (es) 2002-08-29
EA200300537A1 (ru) 2004-02-26
MXPA03006408A (es) 2003-10-15
CZ20031853A3 (cs) 2004-07-14
CA2435121A1 (fr) 2002-07-25
GB0101223D0 (en) 2001-02-28
NO20033223L (no) 2003-07-16

Similar Documents

Publication Publication Date Title
Tabakowska et al. Językoznawstwo kognitywne a poetyka przekładu
EP1467730A4 (fr) Ligands non steroidiens pour le recepteur des corticoides, compositions et utilisations desdits ligands
WO2003105840A3 (fr) Inhibiteurs de sphingosine kinase
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
WO1999048523A3 (fr) Antagonistes de mediateurs inflammatoires
MA26980A1 (fr) Antagonistes des recepteurs d'histamine.
MY135957A (en) Hard precious metal alloy member and method of manufacturing the same
TNSN06187A1 (fr) Arylpyrazoles substitues servant d'agents parasiticides
DE60138228D1 (de) Metallothermische reduktion von oxiden feuerfester metalle
SE0302370D0 (sv) Delay compositions and detonation delay devices utilizing same
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
WO2002089740A3 (fr) Sulfonamides
MA27114A1 (fr) Nouvelle association d'un antithrombotique et d'aspirine
FR2791661B1 (fr) Nouvelles compositions d'oxydes metalliques, des capteurs semi-conducteurs prepares a partir d'une telle composition et leurs utilisations pour la detection des gaz.
FR2860436B1 (fr) Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire
ATE401257T1 (de) Einzeldosisverpackung
ATE346023T1 (de) Monolithisch aufgebauter, basischer, feuerfester keramischer hohlkörper
TW200616749A (en) Welding wire
DE60102704D1 (de) Trioxepan verbindungen
GB0113920D0 (en) Composition
DK1157140T3 (da) Anvendelse af zinklegeringer
UY27124A1 (es) Antagonistas de receptores de histamina
MD2066F1 (en) ntihypertensive remedy
PT1415058E (pt) Um poste